Â鶹ѧÉú¾«Æ·°æ

Tanya Wilcox
( out of 50 reviews )

Tanya Wilcox, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Salt Lake City
801-585-7676

Cardiovascular Center

Cardiovascular Center
Salt Lake City
801-585-7676

  • Dr. Tanya Wilcox completed her medical education at the University of California, Irvine following her undergraduate degree in evolutionary biology at Princeton. She continued her medical training with a residency and chief residency in internal medicine followed by a fellowship in cardiovascular diseases at New York University.

    Dr. Wilcox is a general cardiologist with clinical expertise in preventative cardiology, lipidology, disorders of metabolism, and echocardiography. Her academic interests include investigating the association between metabolic risk factors and cardiovascular disease and perioperative cardiovascular outcomes. She is also interested in medical education and is involved in teaching medical students, residents, and fellows.

    Dr. Wilcox is board certified in internal medicine, cardiovascular diseases and echocardiography. She is also a board certified lipid specialist.

    Specialties

    Board Certification

    American Board of Clinical Lipidology
    American Board of Internal Medicine (Internal Medicine)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 50 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    December 19, 2024
    UH HOSPITALS AND CLINICS

    Dr Wilcox was very friendly and personable. She answered any and all questions I had regarding my health care.

    December 17, 2024
    UH HOSPITALS AND CLINICS

    She is very nice and seems to care about helping me with my heart problem

    December 13, 2024
    UH HOSPITALS AND CLINICS

    Dr. Wilcox was knowledgeable and helpful in caring for my health concerns. She showed kindness and patience in handling any questions or issues that I presented to her.

    November 11, 2024
    UH HOSPITALS AND CLINICS

    She is a wonderful, thoughtful doctor and cares about my health.

    November 08, 2024
    UH HOSPITALS AND CLINICS

    Brief meeting; would liked a bit more time to find out what she assessed from our brief meeting.

    November 05, 2024
    UH HOSPITALS AND CLINICS

    Dr. Wilcox is excellent! I feel lucky to have a provider who is able to understand and treat a genetic lipid disorder.

    October 19, 2024
    UH HOSPITALS AND CLINICS

    Kind and knowledgeable.

    October 09, 2024
    UH HOSPITALS AND CLINICS

    Dr. Wilcox was fantastic. She spent a great deal of time going over my history, getting a good understanding of me, and discussing options. She was very willing to listen and educate. One of the best appointments I have had in a long time!

    October 04, 2024
    UH HOSPITALS AND CLINICS

    Tanya was attentive and asked for my input

    See More Patient Comments

  • Dr. Tanya Wilcox completed her medical education at the University of California, Irvine following her undergraduate degree in evolutionary biology at Princeton. She continued her medical training with a residency and chief residency in internal medicine followed by a fellowship in cardiovascular diseases at New York University.

    Dr. Wilcox is a general cardiologist with clinical expertise in preventative cardiology, lipidology, disorders of metabolism, and echocardiography. Her academic interests include investigating the association between metabolic risk factors and cardiovascular disease and perioperative cardiovascular outcomes. She is also interested in medical education and is involved in teaching medical students, residents, and fellows.

    Dr. Wilcox is board certified in internal medicine, cardiovascular diseases and echocardiography. She is also a board certified lipid specialist.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Clinical Lipidology
    American Board of Internal Medicine (Internal Medicine)
    National Board of Medical Examiners

    Education history

    Fellowship Cardiology - New York University Grossman School of Medicine Fellow
    Chief Resident Internal Medicine - New York University Grossman School of Medicine Chief Resident
    Residency Internal Medicine - New York University Grossman School of Medicine Resident
    Certification Clinical Research Methods - New York University Clinical and Translational Science Institute Certificate
    Internship Internal Medicine - New York University Grossman School of Medicine Intern
    Professional Medical Medicine - University of California, Irvine School of Medicine M.D.
    Undergraduate Ecology and Evolutionary Biology - Princeton University B.A.

    Selected Publications

    Journal Article

    1. Wilcox T, Smilowitz NR, Seda B, Xia Y, Hochman J, Berger JS (2022). Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19. Am J Cardiol, 170, 112-117. ()
    2. Wilcox T, Smilowitz NR, Xia Y, Beckman JA, Berger JS (2020). Cardiovascular Risk Factors and Perioperative Myocardial Infarction After Noncardiac Surgery. Can J Cardiol, 37(2), 224-231. ()
    3. Wilcox T, Smilowitz NR, Xia Y, Berger JS (2019). Cardiovascular Risk Scores to Predict Perioperative Stroke in Noncardiac Surgery. Stroke, 50(8), 2002-2006. ()
    4. Wilcox T, Newman JD, Maldonado TS, Rockman C, Berger JS (2018). Peripheral vascular disease risk in diabetic individuals without coronary heart disease. Atherosclerosis, 275, 419-425. ()
    5. Newman JD, Wilcox T, Smilowitz NR, Berger JS (2018). Influence of Diabetes on Trends in Perioperative Cardiovascular Events. Diabetes Care, 41(6), 1268-1274. ()
    6. Sunseri M, Ahuja T, Wilcox T, Green D (2018). Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis. Case Rep Hematol, 2018, 9501863. ()
    7. Pitzer VE, Viboud C, Alonso WJ, Wilcox T, Metcalf CJ, Steiner CA, Haynes AK, Grenfell BT (2015). Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States. PLoS Pathog, 11(1), e1004591. ()
    8. Tran MH, Lin DM, Wilcox T, Schiro D, Cannesson M, Milliken J (2014). Effects of a multimodality blood conservation schema toward improvement of intraoperative hemoglobin levels and off-pump transfusions in coronary artery bypass graft surgery. Transfusion, 54(10 Pt 2), 2769-74. ()

    Review

    1. Tran MH, Wilcox T, Tran PN (2019). Catheter-related right atrial thrombosis. [Review]. J Vasc Access, 21(3), 300-307. ()
    2. Wilcox T, De Block C, Schwartzbard AZ, Newman JD (2020). Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar. [Review]. J Am Coll Cardiol, 75(16), 1956-1974. ()

  • Clinical Trials